Name: The Patient Empowerment Paradox: Lyme Disease Rhetoric and Contested Health Literacies (en Inglés)
Price: 379425.00 COP
Availability: InStock
Author: Singer, Sarah Ann
ISBN: 9781643365312

portada The Patient Empowerment Paradox: Lyme Disease Rhetoric and Contested Health Literacies (en Inglés)

The Patient Empowerment Paradox: Lyme Disease Rhetoric and Contested Health Literacies (en Inglés)

Formato

Libro Físico

Editorial

University of South Carolina Press

Autor

Singer, Sarah Ann

Año

2026

Idioma

Inglés

N° páginas

276

Encuadernación

Tapa Dura

Dimensiones

22.90 x 15.20 cm

ISBN13

9781643365312

The Patient Empowerment Paradox: Lyme Disease Rhetoric and Contested Health Literacies (en Inglés)

Singer, Sarah Ann (Autor) · University of South Carolina Press · Tapa Dura

Libro Nuevo Importado

Envío: 21 a 25 días háb.

$ 758.849$ 379.425

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 50 unidades

$ 379.425

¡Envío Gratis! Llega entre el 03 Sep y el 10 Sep a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "The Patient Empowerment Paradox: Lyme Disease Rhetoric and Contested Health Literacies (en Inglés)"

How chronic Lyme sheds new light on the rhetorical problem of patient empowermentModern medicine asks patients to be informed and empowered partners in their own care. However, when this care system fails to provide answers, many individuals with chronic and contested illnesses use these same skills of research and advocacy to take matters into their own hands. They seek treatment from providers who confirm their self-diagnoses while touting cures of variable safety and efficacy. Sarah Ann Singer terms this dynamic the patient empowerment paradox.In The Patient Empowerment Paradox, Singer analyzes published narratives, interviews, healthcare provider websites, and a patient data bank, as well as her own experience as a patient, to reveal how individuals become entangled in medical debates, misinformation, and decision fatigue. For Lyme researchers and scholars of other chronic and contested illnesses, she provides a framework to better understand the rhetoric of medical uncertainty and pave the way for improved patient outcomes.